focus -WSS

focus

author：explore 2025-10-02 19:55:29 - browse：9

Stock exchange — Drew Angerer/Getty Images

Viking Therapeutics said Tuesday that its closely watched oral obesity drug had succeeded in an early-stage trial and that it planned to advance the medicine into the next phase of development.

The top-line results released Tuesday were only from a Phase 1 study, which primarily focuses on a drug’s safety. But Viking said that in the study, its medicine led to a roughly 3.3% placebo-adjusted average weight loss after four weeks and that it showed no safety issues.

In preview notes, analysts had said that investors would want to see between 3% and 4% placebo-adjusted weight loss. Shares of San Diego-based Viking were up more than 20% in pre-market trading Tuesday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： NIH chief: government has fallen behind pharma on clinical trials

hotspot

leisure time

WSS

Readout LOUD Podcast: Lilly's obesity drug, the power of radiation

Cancer diagnosis changes perspective doctor, former hospital CEO

Scientific mystery highlights the blind spots in genomics databases

Overprescribed: High cost isn't America's only drug problem

Bird flu in dairy cattle: New measures to control spread to humans

Four alarming medical procedures we’re glad history forgot

leisure time

focus

focus

BioMarin wins approval for gene therapy to treat hemophilia A

Mass General Brigham physicians react to latest merger step

Anesthesiologist group: stop taking Ozempic before surgery

How state and local governments are sidelining science

Apple is now the first public company to be valued at $3 trillion

Overprescribed: High cost isn't America's only drug problem

Guidelines to prevent youth baseball injuries need more muscle

Medicare’s new pay boost for primary care is angering specialists

Malaria cases in Florida and Texas: Here’s what you need to know

What is STAT's opinion section for?

knowledge

How state and local governments are sidelining science

Bird flu in dairy cattle: New measures to control spread to humans

Study: Black kids more likely to die after surgery than white kids

Trial using CRISPR to edit HIV out of cells disappoints

Mass General Brigham physicians react to latest merger step

First transplant of an entire human eye performed

entertainment

hotspot

leisure time

hotspot